Murad Arif, MD
Anesthesiology · Murrieta, CANPI 1164925038
Payments from drug & device makers
Across 398 payments — averaging $71.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Boston Scientific$5K
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- Nevro Corp.$1K
- Collegium Pharmaceutical, Inc.$774
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$727
- plus $3K from 28 others
What the payments were for
- Consulting fees$1,2004%
- Grants$11,25039%
- Travel & lodging$4,52416%
- Food & beverage$11,62741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 77 | $16,086 |
| Boston Scientific | 105 | $4,918 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $1,968 |
| Nevro Corp. | 14 | $1,038 |
| Collegium Pharmaceutical, Inc. | 46 | $774 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $727 |
| AbbVie | 26 | $642 |
| Curonix LLC | 6 | $547 |
| Merck | 2 | $246 |
| Scilex Pharmaceuticals Inc. | 10 | $195 |
| Idorsia Pharmaceuticals US Inc | 10 | $173 |
| Biohaven Pharmaceuticals, Inc. | 6 | $140 |
| Avanos Medical | 4 | $123 |
| Pfizer | 7 | $122 |
| Pacira Therapeutics, Inc. | 1 | $109 |
| Valinor Pharma, LLC | 5 | $90 |
| Si-bone, Inc. | 4 | $86 |
| Vision Quest Industries Inc. | 1 | $68 |
| Cumberland Pharmaceuticals, Inc. | 1 | $66 |
| Vertex | 2 | $61 |
| Azurity Pharmaceuticals, Inc. | 3 | $61 |
| SPR Therapeutics, Inc | 2 | $52 |
| Stryker | 1 | $45 |
| Stimwave Technologies Incorporated | 2 | $40 |
| Octapharma USA, Inc. | 1 | $37 |
| Virtus Pharmaceuticals LLC | 2 | $36 |
| Vertos Medical, Inc. | 1 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Painteq LLC | 1 | $21 |
| Tonix Medicines, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Nalu Medical, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$11,250
- NURTEC ODT$1,768
- SPECTRA WAVEWRITER$1,443
- INTELLIS ADAPTIVESTIM$1,108
- INTELLIS$993
- Senza Spinal Cord Stimulation System$719
- VANTA ADAPTIVESTIM$712
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$416
- WAVEWRITER ALPHA$275
- GENERAL PAIN MANAGEMENT$255
- BRIDION$246
- SUPERION$144
- Omnia$130
- Zilretta$109
How this compares
$28,602 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 17 | $18,310 |
| MovantikNaloxegol Oxalate | 21 | $10,775 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 397 | $10,520 |
| BelbucaBuprenorphine Hcl | 16 | $9,365 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 55 | $6,310 |
| LinzessLinaclotide | 11 | $5,794 |
| Lidocaine | 33 | $4,959 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 151 | $4,947 |
| Buprenorphine | 13 | $4,924 |
| Pregabalin | 182 | $3,792 |
| Oxycodone Hcl | 124 | $2,796 |
| Gabapentin | 117 | $1,958 |
| Celecoxib | 21 | $1,127 |
| Buprenorphine Hcl | 52 | $950 |
| Naloxone Hcl | 16 | $940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $122 | $18,31017 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $774 | $9,36516 claims |
| AbbVieLinzess | $642 | $5,79411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,717 anesthesiology providers in California.
Other anesthesiology in Murrieta
- Kamal MaheshwariSacramento$1.9M
- Gregory HammerStanford$1.8M
- Neal FlemingSacramento$1.7M
- Joseph AntogniniSacramento$1.4M
- Daniel NguyenDuarte$1.4M
- Jack JengSouth San Francisco$1.3M
- Eilon GabelLos Angeles$1.2M
- Philip BicklerSan Francisco$853K
- Joseph RinehartNewport Beach$824K
- Richard Applegate IiLoma Linda$810K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.